The FIRST AND ONLY oral dual PI3K-δ and PI3K-γ inhibitor

 
Please see full Copiktra Prescribing Information including Boxed Warning.

COPIKTRA (duvelisib) is a kinase inhibitor indicated for the treatment of adult patients with:

  • Relapsed or refractory CLL or SLL after at least 2 prior therapies
  • CLL, chronic lymphocytic leukemia; PI3K, phosphoinositide 3-kinase; SLL, small lymphocytic lymphoma; δ, delta; γ, gamma.